HE-4 IN OVARIAN CANCER THERAPY MONITORING: COMPARISON WITH CA 125

被引：0
|
作者：
Molina, R. [1 ]
Escudero, J. M. [1 ]
Auge, J. M. [1 ]
Filella, X. [1 ]
Fuste, P. [1 ]
机构：
[1] Hosp Clin Barcelona, Biochem Lab, Dept Gynecol, Barcelona, Spain
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
76
引用
收藏
页码：6839 / 6839
页数：1
相关论文
共 50 条
  • [41] Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
    Barr, Chloe E.
    Njoku, Kelechi
    Owens, Gemma L.
    Crosbie, Emma J.
    CANCERS, 2023, 15 (04)
  • [42] HE4 combined with CA125: favorable screening tool for ovarian cancer
    Nasrin Ghasemi
    Samira Ghobadzadeh
    Mahnaz Zahraei
    Hemn Mohammadpour
    Salahadin Bahrami
    Mohammad Bakhshi ganje
    Shokoh Rajabi
    Medical Oncology, 2014, 31
  • [43] The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer
    Zhang, Qiong
    Wang, Cong-Rong
    Yu, Juan-Ping
    Ma, Qiang
    Xu, Wei-Wen
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (05) : 709 - 718
  • [44] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
    Molina, Rafael
    Escudero, Jose M.
    Auge, Jose M.
    Filella, Xavier
    Foj, Laura
    Torne, Aureli
    Lejarcegui, Jose
    Pahisa, Jaume
    TUMOR BIOLOGY, 2011, 32 (06) : 1087 - 1095
  • [45] Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses
    Aslan, Koray
    Onan, M. Anil
    Yilmaz, Canan
    Bukan, Neslihan
    Erdem, Mehmet
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2020, 49 (05)
  • [46] Simultaneous Measurement of two Serum Markers (CA-125 and HE-4) while Diagnosing Malignant Ovarian Epithelial Tumors
    Modarres-Gilani, Mitra
    Ghaemmaghami, Fatemeh
    Mousavi, Ashrafossadat
    Abbasi, Fatemeh
    Abdollahi, Alireza
    Shoar, Saeed
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (04) : 858 - 861
  • [47] Meigs' syndrome with elevated CA-125 and HE-4: a case of luteinized fibrothecoma
    Danilos, Jaroslaw
    Kwasniewski, Wojciech Michal
    Mazurek, Diana
    Bednarek, Wieslawa
    Kotarski, Jan
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2015, 14 (02): : 152 - 154
  • [48] CA-125 MONITORING IN THE MANAGEMENT OF OVARIAN-CANCER
    BRUZZONE, M
    ONETTO, M
    CAMPORA, E
    CHIARA, S
    OLIVA, C
    GUIDO, T
    MERLINI, L
    PARODI, S
    BENTIVOGLIO, G
    VENTRELLA, W
    PAGANUZZI, M
    CONTE, P
    ROSSO, R
    ANTICANCER RESEARCH, 1990, 10 (5A) : 1353 - 1359
  • [49] EVALUATION OF THE CLINICAL USEFULNESS OF HE4 AND CA125 ASSAYS IN MONITORING TREATMENT RESPONSE OF PATIENTS WITH ADVANCED OVARIAN CANCER
    Kotowicz, B.
    Fuksiewicz, M.
    Berezowska, A.
    Jalinik, K.
    Bidzinski, M.
    Kowalska, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A483 - A484
  • [50] Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer
    Sugiyama, T
    Nishida, T
    Komai, K
    Nishimura, H
    Yakushiji, M
    Nishimura, H
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 54 (03) : 251 - 256
12345